Tidl Clinical Cryotherapy Menthol Cream

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including those related to arthritis, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, it is recommended to consult a physician prior to use.

The medication should be applied directly to the affected area, adhering to the specified frequency of administration. It is essential to ensure that the application does not exceed the maximum recommended frequency for optimal safety and efficacy.

Contraindications

The product is contraindicated in the following situations:

Application to wounds or damaged skin is prohibited due to the potential for adverse effects. Additionally, application to irritated skin is contraindicated as it may exacerbate the condition. Bandaging the area after application is not recommended, as this may interfere with the product's efficacy and safety. The use of heating pads or devices in conjunction with the product is also contraindicated, as it may lead to increased risk of burns or other complications.

Furthermore, contact with the eyes or mucous membranes must be avoided to prevent irritation or injury.

Warnings and Precautions

For external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Application of this product is contraindicated on wounds or damaged skin, as well as on irritated skin. Healthcare professionals should advise patients against bandaging the area after application, as this may exacerbate potential adverse effects.

Additionally, the use of this product in conjunction with heating pads or devices is not recommended, as it may lead to increased absorption and potential toxicity.

Patients should be instructed to discontinue use if their condition worsens, or if symptoms persist for more than 7 days. If symptoms resolve and then reoccur within a few days, the product should also be stopped, and further evaluation may be necessary.

Side Effects

For external use only. Patients are advised to discontinue use if the condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days. In such cases, it is recommended that patients consult a healthcare professional for further evaluation and guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Tidl Clinical Cryotherapy Menthol Cream (clinical cryotherapy menthol cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of TIDL Clinical Cryotherapy Menthol Cream during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits before recommending this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with any medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and healthcare professionals should ensure that the patient is stabilized. This may involve monitoring vital signs, providing intravenous fluids, and administering symptomatic treatment as necessary.

In the event of an overdose, contacting a poison control center or a medical toxicologist for guidance on specific interventions and antidotes is recommended. Prompt and appropriate management can significantly improve patient outcomes in cases of suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. It is important to instruct patients to avoid contact with the eyes and mucous membranes to prevent irritation or injury.

Patients should be informed not to apply the product to wounds, damaged skin, or areas of irritated skin, as this may exacerbate their condition. Additionally, they should be cautioned against bandaging the area after application, as this could lead to adverse effects.

Healthcare providers should emphasize the importance of washing hands thoroughly with cool water after using the product to ensure safety and hygiene. Patients should also be advised not to use the product in conjunction with heating pads or devices, as this may lead to increased risk of side effects.

Finally, patients should be instructed to monitor their condition closely. If symptoms worsen, or if they persist for more than 7 days, or if symptoms clear up and then reoccur within a few days, they should seek further medical evaluation.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application to the affected area not exceeding 3 to 4 times daily for adults and children aged 12 years and older. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Tidl Clinical Cryotherapy Menthol Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)